This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Hubert Josien
Introduction
Hubert Josien is a notable inventor based in Jersey City, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cardiovascular diseases.
Latest Patents
Hubert Josien holds 1 patent for his work on PCSK9 antagonist compounds. His patent discloses compounds of Formula (I), or a pharmaceutically acceptable salt thereof, which have properties for antagonizing PCSK9. The patent also describes pharmaceutical formulations comprising these compounds and methods for treating cardiovascular diseases and conditions related to PCSK9 activity, such as atherosclerosis, hypercholesterolemia, and coronary heart disease.
Career Highlights
Josien is currently employed at Merck Sharp & Dohme LLC, where he continues to innovate in the pharmaceutical sector. His work has the potential to significantly impact the treatment of various cardiovascular conditions.
Collaborations
Throughout his career, Hubert has collaborated with esteemed colleagues, including Abbas M Walji and Thomas Joseph Tucker. These partnerships have furthered his research and development efforts in the field.
Conclusion
Hubert Josien's contributions to the pharmaceutical industry, particularly through his patent on PCSK9 antagonist compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in cardiovascular disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile